Your search returned 2 results.

Sort
Results
1.
The TRAIL receptor agonist drozitumab targets basal B triple-negative breast cancer cells that express vimentin and Axl. MedStar authors:
  • Swain, Sandra M
PMID:
  • 26759246
Year: 2016
Citation:
  • Breast Cancer Research & Treatment. 155(2):235-51, 2016 Jan.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Amiri-Kordestani L, Chavez KJ, Conway CM, Dine JL, Greer YE, Hewitt SM, Lipkowitz S, Merchant AS, O'Sullivan CC, Sinclair S, Steinberg SM, Stone B, Swain SM, Voeller D
2.
The pathogenesis of atypical proliferative Brenner tumor: an immunohistochemical and molecular genetic analysis. MedStar authors:
  • Seidman, Jeffrey D
PMID:
  • 23887305
Year: 2014
Citation:
  • Modern Pathology. 27(2):231-7, 2014 Feb.
Institution:
  • MedStar Washington Hospital Center
Department:
  • Pathology
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Ayhan A, Kuhn E, Kurman RJ, Seidman JD, Shih IeM
Pages

Powered by Koha